Affiliation:
1. Anhui University of Traditional Chinese Medicine
Abstract
Abstract
Recently, the drug discovery paradigm has evolved from single-target inhibition to a multi-target design concept. This study designed, synthesized, and evaluated a series of novel 2-(indole arylamide) benzoic acid analogs for their in vivo anti-inflammatory properties. Compounds 7f and 7n showed significant anti-inflammatory activity in a xylene-induced mouse model of auricular edema. Furthermore, 7f and 7n exhibited moderate COX-2 inhibitory activity (IC50 = 537 and 321.5 nM) than celecoxib (IC50 = 10.04 nM) in vitro, among which 7n had higher COX-2 selectivity activity (selectivity index (COX-1/COX-2) = 7.89) and moderate 5-LOX inhibitory activity (IC50 = 222.1 nM). Compared to zileuton (IC50 = 36.46 nM), compound 7f was identified as the most potent 5-LOX inhibitor (IC50 = 77.37 nM). According to the biological results, compounds 7f and 7n have better inhibitory activities on the production of NO and PGE2 in LPS-induced RAW 264.7 cell macrophages than celecoxib and indomethacin. As demonstrated by docking studies, 7f and 7n have stronger interactions with key residues in the active pocket of COX-1 or COX-2, which is consistent with the activity results. Based on these results, further research into safer and more effective anti-inflammatory drugs might be possible using 2-(indole arylamide) benzoic acid analogs.
Publisher
Research Square Platform LLC
Reference51 articles.
1. Detection of an anti-angina therapeutic module in the effective population treated by a multi-target drug Danhong injection: a randomized trial;Wang B;Signal Transduct Tar,2021
2. Design, synthesis, in-vitro, in-vivo and in-silico studies of pyrrolidine-2,5-dione derivatives as multitarget anti-inflammatory agents;Jan MS;Eur J Med Chem,2020
3. Origin and physiological roles of inflammation[J];Medzhitov R;Nature,2008
4. 2-Aryl-3- (2-morpholinoethyl) thiazolidin-4-ones: Synthesis, anti-inflammatory in vivo, cytotoxicity in vitro and molecular docking studies[J];Gouvea PD;Eur J Med Chem,2016
5. NSAIDs and cardiovascular risk[J];Marsico F;J Cardiovasc Med,2017